HomeCERS • NASDAQ
add
Cerus Corp
$1.79
Makalipas ang Oras ng Trabaho:(0.56%)-0.0100
$1.78
Sarado: Nob 22, 8:00:00 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$1.67
Sakop ng araw
$1.66 - $1.82
Sakop ng taon
$1.38 - $2.59
Market cap
332.43M USD
Average na Volume
1.94M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 46.02M | 15.70% |
Gastos sa pagpapatakbo | 27.16M | 6.68% |
Net na kita | -2.93M | 59.63% |
Net profit margin | -6.38 | 65.08% |
Kita sa bawat share | -0.02 | 33.33% |
EBITDA | -549.00K | 81.49% |
Aktuwal na % ng binabayarang buwis | -2.66% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 75.56M | -4.36% |
Kabuuang asset | 189.54M | -7.92% |
Kabuuang sagutin | 135.26M | -13.75% |
Kabuuang equity | 54.28M | — |
Natitirang share | 185.72M | — |
Presyo para makapag-book | 5.76 | — |
Return on assets | -1.28% | — |
Return on capital | -1.60% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.93M | 59.63% |
Cash mula sa mga operasyon | 4.07M | 138.80% |
Cash mula sa pag-invest | 4.82M | 1,851.64% |
Cash mula sa financing | 60.00K | -99.21% |
Net change in cash | 9.10M | 378.34% |
Malayang cash flow | -2.85M | 66.42% |
Tungkol
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Itinatag
Set 1991
Headquarters
Website
Mga Empleyado
631
